Sytheon Validates Xerotic Pruritic Skin Topical Treatment
January 29, 2021
Contact Author Michele Behrens
Close
Sytheon evaluated the topical effects of patented isosorbide di-(linoleate/oleate) (IDL) as a xerotic pruritic skin treatment.
Sponsored
Sytheon recently published the results of a study in the
Journal of Investigative Dermatology profiling the mechanistic details of isosorbide di-(linoleate/oleate) and its efficacy as a xerotic pruritic skin treatment.
According to the authors, the breakdown of the epidermal barrier and loss of skin hydration is one of the main contributors to skin aging and eczematous dermatitis. However, there few treatments that resolve these underlying problems to provide full symptomatic relief. With that, Sytheon evaluated the topical effects of its patented isosorbide di-(linoleate/oleate) (IDL) in comparison with ethyl linoleate/oleate.